AtriCure, Inc. (ATRC) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Discovery Group I, LLC mit 1,621,334 Aktien. Weitere bedeutende Anteilseigner sind CARREL MICHAEL H und ROBARDS KAREN P.
In den letzten 12 Monaten haben Insider 38 Transaktionen in ATRC Aktien getätigt — 18 Käufe (im Wert von $106.21K) und 9 Verkäufe (im Wert von $1.19M). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
ATRC Insider-Beteiligungen
Größter Aktionär
Discovery Group I, LLC
1,621,334 Aktien
Käufe (12 Monate)
18
$106.21K Wert
Verkäufe (12 Monate)
9
$1.19M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Discovery Group I, Llc |
10 Percent Owner |
1,621,334 |
2012-12-19 |
|
| 2 |
Carrel Michael H |
President, CEO, & Director |
778,498 |
2026-03-09 |
|
| 3 |
Robards Karen P |
Director |
318,328 |
2016-12-20 |
|
| 4 |
Seith Douglas J |
Chief Operating Officer |
226,756 |
2026-03-03 |
|
| 5 |
Wirick Angela L |
Chief Financial Officer |
204,757 |
2026-03-03 |
|
| 6 |
Privitera Salvatore |
Chief Technical Officer |
155,977 |
2026-03-03 |
|
| 7 |
Wade M. Andrew |
CFO |
140,537 |
2020-07-02 |
|
| 8 |
Lanning Mark R |
Director |
130,886 |
2020-05-22 |
|
| 9 |
White Robert S. |
Director |
112,174 |
2025-05-21 |
|
| 10 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
106,401 |
2026-03-03 |
|
| 11 |
Doraiswamy Vinayak |
Chief Scientific Officer |
96,875 |
2026-03-16 |
|
| 12 |
Dahlquist Karl S. |
Chief Legal Officer |
96,053 |
2026-03-03 |
|
| 13 |
Collar Mark A |
Director |
90,871 |
2022-05-27 |
|
| 14 |
Drachman David J |
President and CEO |
90,000 |
2012-09-13 |
|
| 15 |
Hooven Michael D |
Director |
67,049 |
2017-02-23 |
|
| 16 |
Lux Andrew L |
SVP, Ops & Quality |
66,549 |
2017-07-05 |
|
| 17 |
Kennedy Patricia J |
VP and GM, International |
63,124 |
2015-10-29 |
|
| 18 |
Johnson B Kristine |
Director |
49,810 |
2025-05-21 |
|
| 19 |
Lucky James L |
VP, Clinical, Regulatory & Qs |
46,393 |
2013-03-07 |
|
| 20 |
Yount Deborah Lee |
Chief Human Resources Officer |
45,578 |
2025-03-04 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-12 |
Doraiswamy Vinayak |
Chief Scientific Officer |
Informierter Verkauf |
5,000 |
$29.83 |
$149.15K |
| 2026-03-10 |
White Robert S. |
Director |
Optionsausübung (Verkauf) |
10,000 |
$14.99 |
$149.9K |
| 2026-03-06 |
Carrel Michael H |
President, CEO, & Director |
Schenkung (gegeben) |
1,000 |
- |
- |
| 2026-03-01 |
Doraiswamy Vinayak |
Chief Scientific Officer |
RSU-Steuereinbehalt |
15,585 |
$31.26 |
$487.19K |
| 2026-03-01 |
Dahlquist Karl S. |
Chief Legal Officer |
RSU-Steuereinbehalt |
15,687 |
$31.26 |
$490.38K |
| 2026-03-01 |
Wirick Angela L |
Chief Financial Officer |
RSU-Zuteilung |
39,987 |
- |
- |
| 2026-03-01 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
RSU-Steuereinbehalt |
15,586 |
$31.26 |
$487.22K |
| 2026-03-01 |
Seith Douglas J |
Chief Operating Officer |
RSU-Zuteilung |
42,386 |
- |
- |
| 2026-03-01 |
Privitera Salvatore |
Chief Technical Officer |
RSU-Zuteilung |
30,390 |
- |
- |
| 2026-03-01 |
Carrel Michael H |
President, CEO, & Director |
RSU-Zuteilung |
68,618 |
- |
- |
| 2025-12-31 |
Seith Douglas J |
Chief Operating Officer |
RSU-Zuteilung |
257 |
$27.37 |
$7.03K |
| 2025-12-10 |
Carrel Michael H |
President, CEO, & Director |
Schenkung (gegeben) |
4,000 |
- |
- |
| 2025-11-26 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
Informierter Verkauf |
5,166 |
$37.29 |
$192.64K |
| 2025-11-25 |
Wehrwein Sven |
Director |
Optionsausübung (Verkauf) |
4,967 |
$19.95 |
$99.09K |
| 2025-11-24 |
Wehrwein Sven |
Director |
Optionsausübung (Verkauf) |
5,033 |
$19.95 |
$100.41K |
| 2025-11-21 |
Yuen Maggie |
Director |
Informierter Verkauf |
3,000 |
$35.72 |
$107.16K |
| 2025-11-13 |
Carrel Michael H |
President, CEO, & Director |
Schenkung (gegeben) |
6,000 |
- |
- |
| 2025-09-12 |
Noznesky Justin J |
Chief Mktg & Strategy Officer |
Informierter Verkauf |
3,000 |
$36.30 |
$108.9K |
| 2025-08-22 |
Wehrwein Sven |
Director |
Informierter Verkauf |
5,000 |
$37.00 |
$185K |
| 2025-08-19 |
Wehrwein Sven |
Director |
Informierter Verkauf |
5,000 |
$36.00 |
$180K |
| 2025-08-08 |
Carrel Michael H |
President, CEO, & Director |
Schenkung (gegeben) |
10,000 |
- |
- |
| 2025-08-06 |
Groves Regina E |
Director |
Informierter Verkauf |
2,452 |
$36.82 |
$90.28K |
| 2025-08-05 |
Doraiswamy Vinayak |
Chief Scientific Officer |
Informierter Verkauf |
2,500 |
$36.58 |
$91.45K |
| 2025-06-30 |
Doraiswamy Vinayak |
Chief Scientific Officer |
RSU-Zuteilung |
822 |
$25.84 |
$21.24K |
| 2025-06-30 |
Dahlquist Karl S. |
Chief Legal Officer |
RSU-Zuteilung |
822 |
$25.84 |
$21.24K |
